Hematology › Forums › Hematology MCQ discussion forum › NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs › Reply To: NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs
Answer 54 =  Dxorubicin
Myelosuppression = Dose-limiting toxicity with leukopenia more common than thrombocytopenia or anemia.
Cardiotoxicity = Cummulative Dose-limiting toxicity
 Acute form presents within the first 2–3 days as arrhythmias and/or conduction abnormalities, EKG changes, pericarditis, and/or myocarditis.
 Chronic form results in a dose-dependent, dilated cardiomyopathy associated with congestive heart failure. Risk increases when cumulative doses are greater than 450 mg/m2.
The basic mechanisms of cardiotoxicity may involve direct pathways for reactive oxygen species generation and topoisomerase 2 as well as other indirect pathways.